rs1057516063

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 4P and 5B. PM1PM2BP4BS2

The ENST00000361899.2(MT-ATP6):​c.640T>C​(p.Phe214Leu) variant causes a missense change. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F214S) has been classified as Uncertain significance.

Frequency

Mitomap GenBank:
𝑓 0.0 ( AC: 0 )

Consequence

MT-ATP6
ENST00000361899.2 missense

Scores

Apogee2
Uncertain
0.42

Clinical Significance

Uncertain significance criteria provided, single submitter P:2U:1
EXIT+more-/-bilateral-optic-neuropathy

Conservation

PhyloP100: 5.95

Publications

1 publications found
Variant links:
Genes affected
MT-ATP6 (HGNC:7414): (mitochondrially encoded ATP synthase 6) Contributes to proton-transporting ATP synthase activity, rotational mechanism. Involved in mitochondrial ATP synthesis coupled proton transport. Part of mitochondrial proton-transporting ATP synthase complex. Implicated in Leber hereditary optic neuropathy; NARP syndrome; Parkinson's disease; multiple sclerosis; and systemic lupus erythematosus. [provided by Alliance of Genome Resources, Apr 2022]
MT-CO3 (HGNC:7422): (mitochondrially encoded cytochrome c oxidase III) Predicted to enable electron transfer activity and oxidoreduction-driven active transmembrane transporter activity. Involved in respiratory chain complex IV assembly. Part of respiratory chain complex IV. Implicated in MELAS syndrome. [provided by Alliance of Genome Resources, Apr 2022]
MT-CO3 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary recurrent myoglobinuria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cytochrome-c oxidase deficiency disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leber hereditary optic neuropathy
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome
    Inheritance: Mitochondrial Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 7 benign, 7 uncertain in ENST00000361899.2
PM2
Very low frequency in mitomap database: 0.0
BP4
Apogee2 supports a benign effect, 0.42470115 < 0.5 .
BS2
High AC in GnomadMitoHomoplasmic at 4

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP6unassigned_transcript_4805 c.640T>C p.Phe214Leu missense_variant Exon 1 of 1
COX3unassigned_transcript_4806 c.-41T>C upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MT-ATP6ENST00000361899.2 linkc.640T>C p.Phe214Leu missense_variant Exon 1 of 1 6 ENSP00000354632.2 P00846
MT-CO3ENST00000362079.2 linkc.-41T>C upstream_gene_variant 6 ENSP00000354982.2 P00414

Frequencies

Mitomap GenBank
AF:
0.0
AC:
0
Gnomad homoplasmic
AF:
0.000071
AC:
4
AN:
56429
Gnomad heteroplasmic
AF:
0.000018
AC:
1
AN:
56429
Alfa
AF:
0.000223
Hom.:
1

Mitomap

Disease(s): EXIT+more-/-bilateral-optic-neuropathy
Status: Reported
Publication(s): 32419253

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Mitochondrial disease Pathogenic:1
Oct 01, 2019
Service de Génétique Médicale, Centre Hospitalier Universitaire de Nice-Université Côte d'Azur
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:in vitro

Our patient had the variant m.9166T>C, p.Phe214Leu withProximal muscle weakness, exercise intolerance, myalgia, episodic rhabdomyolysis, and hyperlactatemia -

Optic neuropathy Pathogenic:1
Nov 21, 2016
Center for Neuroscience and Cell Biology, University of Coimbra, Portugal
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Leigh syndrome Uncertain:1
Oct 17, 2019
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The NC_012920.1:m.9166T>C (YP_003024031.1:p.Phe214Leu) variant in MTATP6 gene is interpretated to be a Uncertain Significance variant based on the modified ACMG guidelines (unpublished). This variant meets the following evidence codes: PP3, PP7 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
Apogee2
Uncertain
0.42
Hmtvar
Pathogenic
0.85
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Uncertain
0.10
D
DEOGEN2
Benign
0.38
T
LIST_S2
Uncertain
0.88
D
MutationAssessor
Pathogenic
4.6
H
PhyloP100
5.9
PROVEAN
Pathogenic
-5.2
D
Sift4G
Uncertain
0.0080
D
GERP RS
5.0
Varity_R
0.88
Mutation Taster
=34/66
disease causing

Publications

Other links and lift over

dbSNP: rs1057516063; hg19: chrM-9167; API